PHARMACEUTICAL COMPOSITIONS OF A KINASE INHIBITOR

The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to...

Full description

Saved in:
Bibliographic Details
Main Authors LIEJANTO, Iswadi, CHEN, Tzu-Yuan
Format Patent
LanguageEnglish
Spanish
Published 07.07.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to processes for making the pharmaceutical compositions. La presente invención hace referencia a con composiciones farmacéuticas del inhibidor c-Met, Compuesto 1. La invención también hace referencia a métodos de tratamiento de una enfermedad, un trastorno o un síndrome mediado al menos parcialmente por la modulación de la actividad in vivo de una proteína cinasa con la composición farmacéutica y a procesos para producir las composiciones farmacéuticas.
Bibliography:Application Number: CR20230000223